A Grasso

Summary

Affiliation: Ospedali del Tigullio
Country: Italy

Publications

  1. doi request reprint Late occurrence of pleural and peritoneal effusion due to Mycobacterium tuberculosis infection (TB) in a patient with posttransplantation recurrent HCV chronic hepatitis: safety of peginterferon and ribavirin treatment after recovery of TB:- a case report
    A Grasso
    Internal Medicine and Gastroenterology Unit, San Paolo Hospital, Savona, Italy
    Transplant Proc 40:1783-5. 2008
  2. doi request reprint Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin
    Alessandro Grasso
    Internal Medicine and Gastroenterology Unit, San Paolo Hospital, Via Genova 30, 17100 Savona, Italy
    J Hepatol 51:984-90. 2009
  3. ncbi request reprint Clearance kinetics of hepatitis C virus under different antiviral therapies
    F Torre
    Department of Internal Medicine (DIMI, University of Genoa, Genoa, Italy
    J Med Virol 64:455-9. 2001
  4. ncbi request reprint Therapy of chronic hepatitis C virus infection in HIV co-infected people
    P Fabris
    Dept of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Viale Rodolfi, 36100 Vicenza, Italy
    Curr Pharm Des 10:2111-22. 2004
  5. ncbi request reprint Focal nodular hyperplasia-like areas in cirrhosis
    A Quaglia
    Academic Departments of Histopathology, Radiology Royal Free and University College Medical School, London, UK
    Histopathology 42:14-21. 2003
  6. ncbi request reprint Assessing patients' understanding of hepatitis C virus infection and its impact on their lifestyle
    P Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
    Aliment Pharmacol Ther 23:1161-70. 2006
  7. ncbi request reprint A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin
    A Ciancio
    Dipartimento di Gastroenterologia, Ospedale Molinette, Torino, Italy
    Aliment Pharmacol Ther 24:1079-86. 2006
  8. ncbi request reprint Pegylated interferon and ribavirin in re-treatment of responder-relapser HCV patients
    M Basso
    Department of Internal Medicine, University of Genoa, Viale Benedetto XV, N 6, 16132 Genoa, Italy
    Dig Liver Dis 39:47-51. 2007

Collaborators

  • Paolo Fabris
  • J Tibballs
  • A K Burroughs
  • M Tabone
  • Guido Calleri
  • Annarosa Floreani
  • M Basso
  • A Picciotto
  • F Torre
  • G Percario
  • A Ciancio
  • A Quaglia
  • N Pelli
  • S Blanchi
  • E Azzola
  • S Artioli
  • M Andreoni
  • A Manca
  • G Marenco
  • C Giordanino
  • G Cariti
  • M Gallo
  • P Garbagnoli
  • M Sartori
  • M Anselmo
  • S Cusumano
  • A Smedile
  • G Saracco
  • G Ciccone
  • R Rizzi
  • M Rizzetto
  • A Watkinson
  • N Prasad
  • A P Dhillon
  • P Nozza
  • S E Davies
  • V Balestra
  • R Giusto
  • N Campo
  • R Brizzolara
  • N Sinelli

Detail Information

Publications8

  1. doi request reprint Late occurrence of pleural and peritoneal effusion due to Mycobacterium tuberculosis infection (TB) in a patient with posttransplantation recurrent HCV chronic hepatitis: safety of peginterferon and ribavirin treatment after recovery of TB:- a case report
    A Grasso
    Internal Medicine and Gastroenterology Unit, San Paolo Hospital, Savona, Italy
    Transplant Proc 40:1783-5. 2008
    ..The infection was successfully treated with no hepatotoxicity or rejection, so that it was possible to start antiviral treatment with peginterferon and ribavirin for recurrent HCV without reactivation of MT infection...
  2. doi request reprint Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin
    Alessandro Grasso
    Internal Medicine and Gastroenterology Unit, San Paolo Hospital, Via Genova 30, 17100 Savona, Italy
    J Hepatol 51:984-90. 2009
    ..However, the variables influencing the early phase of viral decay are still largely unexplored. We aimed to assess which pre-treatment variable may predict rapid virologic response (RVR) and sustained virologic response (SVR)...
  3. ncbi request reprint Clearance kinetics of hepatitis C virus under different antiviral therapies
    F Torre
    Department of Internal Medicine (DIMI, University of Genoa, Genoa, Italy
    J Med Virol 64:455-9. 2001
    ..A new dynamic approach to HCV treatment can therefore be developed...
  4. ncbi request reprint Therapy of chronic hepatitis C virus infection in HIV co-infected people
    P Fabris
    Dept of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Viale Rodolfi, 36100 Vicenza, Italy
    Curr Pharm Des 10:2111-22. 2004
    ..Liver transplantation is being evaluated in many centers. To date the experiences are very limited but encouraging in term of survival rate...
  5. ncbi request reprint Focal nodular hyperplasia-like areas in cirrhosis
    A Quaglia
    Academic Departments of Histopathology, Radiology Royal Free and University College Medical School, London, UK
    Histopathology 42:14-21. 2003
    ..Focal nodular hyperplasia-like lesions have rarely been described in cirrhotic livers. We describe five cases of such lesions...
  6. ncbi request reprint Assessing patients' understanding of hepatitis C virus infection and its impact on their lifestyle
    P Fabris
    Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
    Aliment Pharmacol Ther 23:1161-70. 2006
    ..To assess how much patients with hepatitis C virus infection know about their condition and what impact it has on their lifestyle...
  7. ncbi request reprint A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin
    A Ciancio
    Dipartimento di Gastroenterologia, Ospedale Molinette, Torino, Italy
    Aliment Pharmacol Ther 24:1079-86. 2006
    ..There is yet no established treatment for chronic hepatitis C patients non-responder to standard interferon and ribavirin...
  8. ncbi request reprint Pegylated interferon and ribavirin in re-treatment of responder-relapser HCV patients
    M Basso
    Department of Internal Medicine, University of Genoa, Viale Benedetto XV, N 6, 16132 Genoa, Italy
    Dig Liver Dis 39:47-51. 2007
    ..The re-treatment of patients who relapse after a course of standard interferon and ribavirin with pegylated interferon alfa-2b plus ribavirin is an open issue...